Exploring cancer patient immune monitoring data in clinical trials
PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trials
This study is looking at ways to make cancer treatments work better by finding new signs that show how well patients respond to immunotherapy and what side effects they might experience, all while creating easy-to-understand tools to help everyone involved communicate better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10294555 on NIH RePORTER |
What this research studies
This research focuses on improving cancer immunotherapy by analyzing complex immune monitoring data from clinical trials. It aims to identify new biomarkers that can predict how patients respond to treatment and to uncover potential side effects, such as colitis. By developing advanced visualization tools, the project seeks to make sense of diverse data types, enhancing communication and understanding of patient responses. This approach is part of a broader initiative to optimize cancer treatment and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing immunotherapy who may benefit from enhanced monitoring of their immune responses.
Not a fit: Patients who are not receiving immunotherapy or those with non-malignant conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments, minimizing side effects and maximizing patient benefit.
How similar studies have performed: Other research initiatives have shown promise in utilizing advanced data analysis and visualization techniques to improve cancer treatment outcomes, indicating a potential for success in this approach.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Gumus, Zeynep Hulya — Icahn School of Medicine at Mount Sinai
- Study coordinator: Gumus, Zeynep Hulya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.